MetaCap

Stoke Therapeutics (STOK) vs First Tracks Biotherapeutics (TRAX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Stoke Therapeutics is the larger company by market cap ($1.75 billion vs $1.75 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

STOK-18.24%TRAX+119.16%
+186%+72%-42%
Apr 6, 20261 yearNov 20, 2026
STOK-21.91%TRAX+77.19%
+111%+36%-39%
Apr 6, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

STOK versus TRAX key metrics
MetricSTOKTRAX
Share price$26.81$41.64
Market cap$1.75B$1.75B
1-day change-0.45%-6.34%
YTD return-15.53%—
1-year return-8.62%—
5-year return+6.77%—
EPS (TTM)$-3.81$-4.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$184.42M—
Revenue growth (YoY)+404.50%—
Net income (latest FY)$-6.88M—
Operating margin-11.16%—
Net margin-3.73%—
52-week high$40.22$54.78
52-week low$22.05$14.72
Distance from 52-week high-33.34%-23.99%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+73.00%+80.52%
Average volume1.02M826.70K
Shares outstanding65.41M42.02M
Employees170104
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Stoke Therapeutics

STOK stock →

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Health Care · Biotechnology: Pharmaceutical Preparations · 170 employees

About First Tracks Biotherapeutics

TRAX stock →

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees

STOK vs TRAX FAQ

Which is bigger, Stoke Therapeutics or First Tracks Biotherapeutics?

Stoke Therapeutics (STOK) is larger, with a market capitalization of $1.75B compared with $1.75B for First Tracks Biotherapeutics (TRAX).

Are Stoke Therapeutics and First Tracks Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons